DDR1 and neoplasm: To determine whether the DDR1-IN-1 antibody could suppress COL4A6-mediated tumor growth in vivo, mice were injected intraperitoneally with 1 × 106 A2780/COL4A6 cells and then treated with an intraperitoneal injection of DDR1-IN-1 with or without cisplatin.